Search results
3 days ago · A webcast of the Annual General Meeting of Shareholders of QIAGEN N.V. ("AGM") will be hosted on Friday, June 21, 2024, at 10:00 a.m. (CET) Register Now.
- Investor Relations
By providing your email address below, you are providing...
- Events & Presentations
By providing your email address below, you are providing...
- Newsroom
QIAGEN N.V. verpflichtet sich, Ihre Daten mit Respekt zu...
- Investor Relations
2 days ago · QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of March 31, 2024, QIAGEN employed more than 5,900 people in over 35 locations worldwide.
2 days ago · QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of March 31, 2024, QIAGEN employed more than 5,900 people in over 35 locations worldwide.
1 day ago · QIAGEN N.V. QGEN recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis (TB) infection with modern blood-based tests ...
2 days ago · Germantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis (TB) infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus (QFT-Plus).
2 days ago · HGMD Professional 2024. 2 is now available, adding 9,075 new gene mutation entries to the world’s largest collection of expert-curated data on germline mutations in nuclear genes underlying or associated with human inherited disease. The new summer 2024 release brings the total of disease-associated germline mutations in HGMD Professional to ...
1 day ago · Wolfe Research upgraded Qiagen ( NYSE: QGEN) to Outperform from Peer Perform on Thursday, noting a valuation disconnect between the Dutch life sciences company and its peers. However, analyst Doug ...